Longeveron Inc.

NASDAQ (USD): Longeveron Inc. (LGVN)

Last Price


Today's Change

-0.66 (14.50%)

Day's Change

3.80 - 4.94

Trading Volume



Market Cap

Shares Outstanding

Avg Volume

Avg Price (50 Days)

Avg Price (200 Days)

PE Ratio


Earnings Announcement

Previous Close


Day's Range

Year Range

Trading Volume

Price Change Highlight

1 Day Change

5 Day Change

1 Month Change

3 Month Change

6 Month Change

Ytd Change

1 Year Change

3 Year Change

5 Year Change

10 Year Change

Max Change

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology


Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.

Be the first to like this. Showing 0 of 0 comments

Post a Comment